Methscopolamine
From Wikipedia, the free encyclopedia
 |
|
|
Methscopolamine
|
|
| Systematic (IUPAC) name | |
| ? | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C18H24NO4 |
| Mol. mass | 318.388 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Methscopolamine, usually provided as a bromide salt (Pamine), is an oral medication used along with other medications to treat peptic ulcers by reducing stomach acid secretion. It can also be used for stomach or intestinal spasms, to reduce salivation, and to treat motion sickness. Methscopolamine is also commonly used as a drying agent, to dry up post-nasal drip, in cold and allergy medications (Extendryl, AlleRx, Rescon).
Methscopolamine, a methylated derivative of scopolamine, is a muscarinic antagonist structurally similar to the neurotransmitter acetylcholine. Its mechanism of action involves blocking the muscarinic acetylcholine receptors.
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
